Welcome and Opening Remarks
Overview: What is CMT? – Michael Shy, MD
Overview: What is CMT? – Dr. Stephan Züchner, MD, PhD
Goals & Objectives for the Meeting, Participant Polling of Demographic Questions
Session 1: Symptoms and Daily Challenges for Pediatrics & Young Adults
Session 3: Current and Future Approaches to Treatments
Pipeline Overview Therapies in Development – Florian Thomas, MD, MA, PhD, MS
Summary from FDA & Closing Remarks
0 Comments